BMP13 Prevents the Effects of Annular Injury in an Ovine Model by Wei, Aiqun et al.
Int. J. Biol. Sci. 2009, 5 
 
 
http://www.biolsci.org 
388
I In nt te er rn na at ti io on na al l   J Jo ou ur rn na al l   o of f   B Bi io ol lo og gi ic ca al l   S Sc ci ie en nc ce es s   
2009; 5(5):388-396 
© Ivyspring International Publisher. All rights reserved 
Short Research Communication 
BMP13 Prevents the Effects of Annular Injury in an Ovine Model 
Aiqun Wei, Lisa A Williams, Divya Bhargav, Bojiang Shen, Thomas Kishen, Neil Duffy and Ashish D Diwan 

 
Disc Biology Group, Orthopaedic Research Institute and Department of Orthopaedic Surgery, St George Hospital, Univer-
sity of New South Wales, Sydney, Australia   

 Correspondence to: Dr Ashish Diwan, Orthopaedic Research Institute, St George Clinical School, The University of New 
South Wales, 4-10 South Street, Kogarah, NSW 2217. Tel: 61-2-9588 9622; Fax: 61-2-9588 9722; E-mail: 
a.diwan@spine-service.org 
Received: 2009.04.02; Accepted: 2009.05.30; Published: 2009.06.03 
Abstract 
Chronic back pain is a global health problem affecting millions of people worldwide and car-
ries significant economic and social morbidities. Intervertebral disc damage and degeneration 
is a major cause of back pain, characterised by histological and biochemical changes that have 
been well documented in animal models. Recently there has been intense interest in early 
intervention in disc degeneration using growth factors or stem cell transplantation, to re-
plenish the diseased tissues. Bone Morphogenetic Proteins (BMPs) have been approved for 
clinical use in augmenting spinal fusions, and may represent candidate molecules for in-
tervertebral disc regeneration.   
BMP13 has an important role in embryonic development and recent genetic evidence shows 
a role in the development of the human spine. This study explores the effect of BMP13 on a 
damaged intervertebral disc in an ovine model of discal degeneration. We found that, when 
injected at the time of injury, BMP13 reversed or arrested histological changes that occurred 
in the control discs such as loss of extracellular matrix proteins. In addition, BMP13 injected 
discs retained greater hydration after 4months, and possessed more cells in the NP.   
Taken together, BMP13 may be a potent clinical therapeutic agent when used early in the 
degeneration cascade to promote healthy disc tissue. 
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1. INTRODUCTION 
Back pain is at epidemic levels in Western coun-
tries and growing in significance as societies and 
emerging economies age. Disturbances of the in-
tervertebral disc (IVD) such as herniation and degen-
erative changes are a major cause of pain. The IVD, 
with its central, highly hydrated proteoglycan-rich 
gelatinous core nucleus pulposus (NP) and outer, 
high tensile, collagen I fibre-rich annulus fibrosus 
(AF) is responsible for much of the tensile strength 
and cushioning of the spine [1]. Damage or injury to 
either of these structures leads to degenerative bio-
chemical and biomechanical changes that can cause 
pain and loss of function [2].   
The current treatment options for chronic back 
pain depend on its severity and persistence for any 
individual patient. In a proportion of patients pain 
persists and treatment will involve various major in-
vasive surgeries including partial or total disc re-
placement and, as a last resort, spinal fusion. Treat-
ment solutions that target early disc degeneration are 
eagerly sought [3,4]. 
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to stimulate the growth of skeletal tissues in both de-
veloping and adult tissues [5] and are used to aug-
ment spinal fusion. BMP-7, BMP-2 and BMP-14 have 
also been tested in animal models of IVD regeneration 
[6-8]. BMP13 (also known as growth & differentiation 
factor-6, GDF6 and cartilage derived morphogenetic 
protein-2, CDMP2) has an important role in early 
embryonic and ocular development [9] and more re-
cently was shown to play a role in spinal column de-
velopment [10]. Congenital gene mutations caused 
spinal vertebral fusions, perhaps revealing a crucial 
role for BMP13 in disc tissues which could be applied 
to adult tissue maintenance and repair. In vitro studies 
suggest BMP13 promotes the expression of chondro-
genic marker genes in a variety of cell types [9,11,12] 
including bovine intervertebral disc [13,14]. Indeed 
BMP13 was recently shown to inhibit expression of 
both early and late markers of osteogenic differentia-
tion in vitro [15]. BMP13 may be a candidate disc re-
generation molecule with a reduced risk of bone for-
mation in the IVD. 
A sheep model has been developed to study 
slow degeneration of the IVD using histological and 
biochemical analysis [16-18]. This study aimed to 
examine the effect of a single injection of recombinant 
human BMP13 protein at the site of a controlled, con-
sistent annular stab injury in an ovine pilot study us-
ing histological, immunohistochemical, magnetic 
resonance imaging (MRI) and x-ray analyses to ad-
dress whether early discal degeneration could be ef-
fectively halted or reversed with application of 
BMP13.  
 
2. MATERIALS AND METHODS 
Animal Model 
Seven male merino wethers aged 2-4yrs were 
entered into this study. For each sheep, four lumbar 
discs received either: annular puncture, annular 
puncture plus BMP13 injection; surgical exposure 
only (exposed control), or no surgical exposure (non 
visualized control). The study, was based on an es-
tablished sheep annular stab model previously de-
scribed [16,17] and was approved by the Animal Eth-
ics Committee, University of Sydney, Australia. 
The surgical procedure was performed under 
general anesthesia, where the fibrosus annuli of an-
terolateral discs of L2 to L5 were exposed and an in-
cision in the fibrous annulus was made to a 6mm 
depth using a #11 B-P knife in two discs, with an ad-
ditional surgically exposed disc used as a control. A 
27mm x 10mm titanium screw was implanted into one 
of the vertebral bodies for later identification of levels. 
One of the punctured levels received 300μg of BMP13 
in 70μl saline immediately following annular punc-
ture, whereas the other one received the same volume 
of saline (70μl) alone. Following surgery, the sheep 
were monitored for 2-3 days postoperatively and then 
returned to the field.  
Radiograph and Images 
X-ray images of the lumbar region were taken 
immediately post surgery, at 14 days post surgery and 
thereafter prior to euthanasia. X-ray images of indi-
vidual animals immediately post surgery (T0) and 
after 4months (T4), were examined and compared for 
statistical relationships in discal height. The vertebral 
body and disc heights were converted to a ratio and 
measured by 3 investigators as described previously 
[19]. The average disc height was expressed as the 
disc height index (DHI), generated from three meas-
urements. 
Within 5 hours of harvesting of the whole spine, 
at each time point, MRI and CT scan images were 
collected. Sagittal MRI scans were acquired using a 
0.25 Tesla low field Esaöte G-scan imager with a T2 
pulse sequence, 4mm slice thickness. Parameters in-
cluded a 30cm2 field of view, a 224x208 matrix, an 
echo time of 120 milliseconds, and a repetition time of 
2790 milliseconds. 
Serial axial thin-cut CT scans (Siemens, Cardiac 
Sensation 64 Slice, Germany) of L1-S1 were performed 
for all specimens. A sagittal reconstruction of images 
across the L1–S1 inter-transverse process regions was 
obtained. The images were examined by two, blinded 
observers experienced in MRI and CT scan image 
interpretation for disc health. The quality of disc 
health was determined by the signal intensity of the 
discs on T2-weighted MRI images where degenerated 
discs were darker coloured in predominantly the NP 
region.  
Histological Analysis  
The sheep were euthanized at 4 (n=3), 8 (n=2), 
and 12 (n=2) months post surgery. The IVDs (L2–L5) 
and vertebrae were immediately procured, fixed in 
10% neutral buffered formalin and thereafter decalci-
fied in rapid decalcification solution (RDO solution, 
Lomb Scientific Australia). The disc tissues were cut 
and then paraffin-embedded for para-sagittal and 
coronal sectioning. The 4μm sections were stained 
with hematoxylin-eosin (H&E) for routine histology 
and Safranin-O/Fast green to identify proteoglycan 
(red) and collagen (blue). 
To semi-quantify cell numbers in the NP and 
inner endplate, counting of cells was performed on 
H&E stained sections, with 4-6 slides each, under a Int. J. Biol. Sci. 2009, 5 
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20x light microscope objective. Cells were counted in 
randomly selected areas of the EP zones of the NP by 
3 researchers independently. Cells were also counted 
in images of the inner NP were also counted sepa-
rately by three researchers.  
Sections were also viewed using a digital imag-
ing workstation under polarized light (DM6000 B; 
Leica Microsystems). Comparisons of inter-lamellar 
fibre distribution and the surrounding matrix archi-
tecture of the AF zones were made using unstained 
sections. 
Semi-Quantitative Detection of Proteoglycans 
Proteoglycans were visualised with Alcian blue 
staining. Briefly, sections were deparaffinized, hy-
drated through a graded ethanol series and stained in 
1% (w/v) Alcian blue (Sigma) solution in 3% (w/v) 
glacial acetic acid, pH 4.2, for 30 minutes, followed by 
a tap water wash for 10 minutes. The samples were 
counter-stained with nuclear red solution (0.1% nu-
clear fast-red in 5 % aluminium sulphate), followed by 
several washes in water.  
To quantify the proteoglycans in the disc, Alcian 
blue stained slides were analysed using ImageJ soft-
ware. Rectangular Regions of Interest (ROI) in both 
AF and NP were selected on scanned images of slides 
of each disc. The numbers of pixels in the ROI for each 
of 255 shades of blue were counted. The sum of these 
intensity values was then divided by the total number 
of pixels in the region, giving a (unit-less) 
semi-quantitative measure of Alcian blue stain for 
each sample.  
Immunohistochemistry 
The sections were deparaffinized and hydrated 
through a graded ethanol series. Endogenous per-
oxidases were scavenged with 3% (v/v) H2O2 and 
non-specific binding sites were blocked with 10% 
skim milk powder/Tris-HCl buffer. The slides were 
then probed with primary rabbit polyclonal antibod-
ies specific for type-I (1:100) and type-II (1:150) colla-
gen (Research Diagnostics I N C ,  F l a n d e r s  N J ) .  T h e  
slides were treated with Multilink solution (DAKO, 
Sydney, Australia) followed by strepta-
vidin-conjugated peroxidase incubation. Results were 
visualized with a 3,3'-diaminobenzidine hydrochlo-
ride (DAB, DAKO) solution and counterstained in 
Haematoxylin. The primary antibody was omitted for 
negative controls. 
Statistics 
Comparisons between multiple experimental 
groups were performed with analysis of variance 
(ANOVA) and Student’s t test using Sigma Stat soft-
ware (SPSS Inc., San Rafael, CA). X-ray images were 
compared before and after each time point using a 
paired Student’s t test. All values are presented as 
mean ± standard error (SEM). 
 
3. RESULTS AND DISCUSSION 
BMP13 Injection Protects Against Disc Degen-
eration 
Evidence of intervertebral disc degeneration can 
be visualised using magnetic resonance or x-ray im-
aging [19,20]. Figure 1 shows representative images of 
CT and MRI scanned sheep spines at 4months post 
annular injury (Figure 1A, B) and x-ray images of a 
sheep spine immediately after surgery (T0) and post 
mortem after 4 months (T4). Narrowing of the in-
tervertebral disc was visible in the CT scan (Figure 
1A). The MRI image (Figure 1B) reveals that the 
stabbed disc has deteriorated and lost its water con-
tent, displaying a darker core disc structure. This loss 
of hydration in the disc has also been shown bio-
chemically [18] within this time frame (6 months). The 
control and BMP13-injected discs, however, have 
healthy, lighter shading in the disc nucleus.  
The x-ray image shows obvious narrowing of the 
stabbed disc from one of three sheep spines after 4 
months (Figure 1C), whereas control and 
BMP-injected disc heights do not appear to have nar-
rowed. After 8 and 12 months all of the stabbed discs 
showed narrowing, relative to control and 
BMP13-injected discs (not shown). Quantitative ex-
amination of the x-ray images to assess changes in 
DHI over time showed the disc narrowing was statis-
tically significant in the stabbed, but not the 
BMP13-injected or control discs at 8- and 12-months 
post surgery (Figure 1D) using three independent 
measurements. The DHI change was not statistically 
significant at 4 months. Consistent with this data, 
moderate disc narrowing at 4-6 months post-injury 
was reported using this model in about half of sub-
jects [17], with more consistent loss of disc height at 
8-12 months. Similarly DHI recovery was reported in 
a rabbit model of discal injury following BMP-7 [7] 
and GDF-5 [6] injection, but not with BMP-2 expres-
sion from transfected cells [8]. 
Thus it appears that injection of BMP13 at the 
time of injury could prevent or at least slow down the 
deterioration of the intervertebral disc. 
BMP13 maintains cell numbers in the Nucleus 
Pulposus  
Examination of sections stained with H&E 
showed that cells appeared to be discharging from the 
discal side of the EP into the NP and the inner AF 
(Figure 2A). Most of these cells morphologically ap-Int. J. Biol. Sci. 2009, 5 
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peared round with a single nucleus, and were found 
in lines, aligned towards the NP and inner AF (Figure 
2A). Expression of collagen II (Figure 2B), but not 
collagen I (not shown), was observed by immu-
nostaining.  
Quantification of the chondrocyte-like cells 
demonstrated that a stab injury to the annulus re-
sulted in a significant (32%) loss of cells (P< 0.05) from 
the disc (Figure 2C), compared with controls. How-
ever with BMP13 injection the cell numbers were 
boosted to the level of control discs. There was also 
evidence of neo-vascularization, a known response to 
chronic injury and a characteristic of this model [16], 
which we observed on the bony side of the EP region 
in injured but not in BMP13-injected disc tissues 
(Figure 2a). This data suggests that BMP13, when in-
jected directly into the disc, may reverse or prevent 
early degenerative changes induced by mechanical 
injury through cell mobilization from the EP cartilage, 
or prevention of cell loss. Whether this effect was 
mediated by stimulatory signals or by the prevention 
of cell apoptosis, as was shown for BMP-7 in disc cells 
[21], cannot be concluded here. BMPs are known 
chemo attractants for many cell types [22,23] and 
BMP13 may also stimulate cell migration. The nature 
of the cells moving into the NP cannot be distin-
guished here, although they appear somewhat chon-
drocyte-like. Cells resembling progenitors have been 
identified in the disc NP [24] but lack of antibody re-
agents specific for sheep antigens precludes further 
analysis of the EP-NP zone cells in this study.  
BMP13 Increases Collagen Production  
Under polarized light, we observed numerous 
bright collagen bundled lamellae in the annulus of 
control discs (Figure 3A). Their bundles of collagen 
fibres were bright, well organized and tightly bound 
by the surrounding matrix. However, following an-
nular stab injury there appears to have been a sub-
stantial loss of collagen and lamellae structure in the 
AF, as shown by the dull image (Figure 3A). Loss of 
collagen has been previously reported in the ovine 
annular puncture model [18] although it occurred 
more gradually over a 12 month period. Injection of 
BMP13 at the time of injury resulted in the deposition 
of a mass of collagen, visible as brightly 
light-reflecting collagen bundled lamellae in the AF 
(Figure 3A). Immunohistochemical staining with spe-
cific antibodies shows that the majority of this newly 
deposited collagen is collagen II (Figure 3C), as 
minimal staining is visible with specific collagen I 
antibodies (Figure 3B). An increase in expression of 
collagen II (Figure 3C) in the inner region of the AF 
was found in the BMP13 injected group compared 
with stabbed or surgically exposed control tissues. 
This data is consistent with several previous reports 
demonstrating that BMP13 can induce expression of 
collagen II in vitro [15,25,26]. High levels of collagen II 
is a marker of NP tissue and a characteristic of 
disc-like cells. Thus, immunostaining indicates that 
the addition of BMP13 at the time of annular stab in-
jury results in the retention of, or the stimulation of 
new synthesis of disc extracellular matrix proteins 
compared to annular stab alone.  
 
BMP13 Increases Proteoglycan Production  
Histological staining of the disc tissue showed 
BMP13 had an effect not only on cell numbers, but on 
the extracellular matrix production of cells in the disc.  
At low magnification the original colour inten-
sity stained by Safranin-O & light green (Figure 4A) 
and Alcian blue (Figure 4B) was reduced in the 
stabbed discs at the 4 month time point compared 
with BMP13 injection and controls. This was also ob-
served in the stabbed discs at both the 8 month and 12 
month time points (not shown). Under high magnifi-
cation, positive blue staining was seen in both AF (not 
shown) and NP (Figure 4C) regions. Production of 
large amounts of proteoglycan in the NP of the con-
trols and BMP13 injection group but not in stabbed 
disc tissue (Figure 4C) was observed. Several in vitro 
studies have shown BMP13 stimulation of proteogly-
can production in a variety of cells [13,14,27], sug-
gesting the increased staining in BMP13-injected tis-
sue samples may represent new synthesis as well as 
retention of existing proteoglycan. This may also be 
the mechanism of BMP13 injection influencing the 
hydration of the disc tissues, as proteoglycan mole-
cules retain water molecules.  
Semi-quantitation of Alcian blue stained pro-
teoglycan demonstrated considerable loss of pro-
teoglycan from stabbed discs, yet those which re-
ceived BMP13 injection had a five fold greater inten-
sity of Alcian blue staining, often above that of ex-
posed control levels (Figure 4C, 4D). 
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Figure 1. BMP13 injection following annular stab protects discs from degeneration. A representative CT scan (A), MRI 
scan (B) of lumbar discs and 4 months post surgical stab injury and radiographs immediately after and 4 months following 
surgery (C). Progressive changes in the stabbed discs (st) are visible in all images when compared with the untouched 
control (cn), the surgically exposed control (ex) and BMP13 (bm) injection. The MRI image shows the decreased signal 
intensity of the nucleus pulposus area for the stabbed disc at 4 months post surgery, compared to controls. The BMP13 
injected disc shows the brighter, increased signal intensity for the disc area, similar to controls (B). A graphical repre-
sentation of DHI shows that a significant difference in DHI was present in the stabbed disc group when “T0” and “T8/12” 
surgery measurements were compared at 8 months, and at 12 months (D). Measurements of vertebral body height and 
intervertebral disc height were obtained from radiographs using imageJ software. Disc Height Index (DHI) was calculated as 
previously described [19]. *p<0.01 comparing corresponding DHI from “T0” to “Tx” surgery at teach time point. Data are 
presented as mean±SD from three individual blinded measurements. Int. J. Biol. Sci. 2009, 5 
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Figure 2. BMP13 injection increased cell numbers within the disc NP and inner AF. A representative image of H&E stained 
disc tissues shows that more chondrocyte – like cells are present at the NP – EP juncture in BMP13 injected disc tissues 
when compared with annular stab alone (A).  These cells appear to be moving toward the region of the NP (B, top panel).  
Immunohistochemical staining revealed collagen II expression in the EP and in these moving cells (B, top panel). High 
magnification revealed that the cells were chondrocytic in appearance with a round or oval shape and a small nucleus (B, 
lower panel, Arrow indicated). Images were captured at x 200 (A and B, top panel) and x 1000 (B, lower panel) magnification. 
Graphical representations of the cell counts were performed at the NP – EP juncture under a 20X light microscope ob-
jective (C). *p<0.05 compared to stabbed or exposed disc tissues. Data are presented as mean±SE from 3 individual 
measurements from six sample images for each group. 
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Figure 3. BMP13 injection stimulates collagen synthesis in the AF. Representative polarized light images show numerous 
well organized bright collagen bundled lamellae separated by an interlamellar space in the annulus of the controls (including 
surgically-exposed and non-visualised control discs). Even though disorganized, bright collagen lamellae were observed in 
BMP13-injected discs, particularly at the edges of the stab injury track itself (A).  Original magnification: x100 (A-top panel) 
and x400 (A-lower panel). There was an observable loss of basic structure and of collagen in the stabbed discs and the 
stab-track continued to be obvious with limited repair (A). Immunostaining showed that collagen 1 was expressed within the 
bundled lamellae of the AF (B), whilst an increase in collagen II expression was observed within the lamellae of inner AF in 
both the control and BMP13-injected groups (C) when compared with the stabbed group at the 4 month time point (C). The 
collagen fibre meshworks which were intensively stained with collagen II were visualised with branched out collagen bundles 
into the interlamellar spaces in the control and BMP13 injected groups. No such collagen meshworks were observed in 
stabbed disc tissues (C).  Original magnification: x 100 (B,C). Int. J. Biol. Sci. 2009, 5 
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Figure 4. BMP13 injection stimulated Proteoglycan production. Representative images of Safranin-O/Light green staining 
(A) and Alcian blue staining (B) of sheep disc tissues. Orange (A) or blue (B) colour intensity decreased in the AF of stabbed 
discs in comparison to control or BMP13 injected tissues. Microscopic images of the NP of discs positively stained with 
Alcian blue in the control and BMP13- injected tissue groups (C), but significant loss of Alcian blue stained proteoglycan in 
the stab-alone tissues (C). Original magnification: x 400 (C). Graphical representation of the intensity of blue stained disc 
tissues (D); was calculated by ImageJ software.  Data presented represents the blue color intensity from total image pixles. 
The mean and SD for three individual samples for each group are shown. *p<0.05 compared to all the groups. 
 
 
4. CONCLUSION 
This report, whilst using small numbers of ani-
mals, provides us with encouraging evidence of the 
efficacy and potential of BMP13 for the treatment of 
intervertebral disc degeneration. The annular stab 
injury resulted in detectable disc deterioration as early 
as 4 months and clearly demonstrated the loss of disc 
extracellular matrix proteins as well as disc narrowing 
and water loss. A single injection of recombinant 
BMP13 improved the disc health following annular 
stab in every parameter studied, including protecting 
the disc from narrowing and replenishment of the 
extracellular matrix. This represents the first demon-Int. J. Biol. Sci. 2009, 5 
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stration of BMP13 as a candidate therapeutic agent 
and suggests further, larger studies to assess efficacy 
and safety are immediately warranted.  
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